1.

[Report] European Union Drugs Agency. (2025) New psychoactive substances – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

2.

[Report] An Garda Siochana. (2025) An Garda Síochána annual report 2023. Dublin: An Garda Siochana.

3.

[Webpage] United Nations Office on Drugs and Crime. (2025) UNODC Early warning advisory (EWA) on new psychoactive substances (NPS). URL: https://www.unodc.org/LSS/Home/NPS

4.

[Report] United Nations Office on Drugs and Crime. (2024) The challenge of new psychoactive substances - a technical update. Vienna: United Nations.

5.

[Article] Uthaug, Malin Vedøy and Davis, Alan K and Haas, Trevor Forrest and Davis, Dawn and Dolan, Sean B and Lancelotta, Rafael and Timmermann, Christopher and Ramaekers, Johannes G (2022) The epidemiology of mescaline use: pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. Journal of Psychopharmacology, 36, (3), pp. 309-320. doi: 10.1177/02698811211013583

6.

[Article] Fattore, Liana and Marti, Matteo and Mostallino, Rafaela and Castelli, Maria Paola (2020) Sex and gender differences in the effects of novel psychoactive substances. Brain Sciences, 10, (9). doi: 10.3390/brainsci10090606

7.

[Report] WHO Expert Committee on Drug Dependence. (2017) 39th Expert Committee on Drug Dependence: technical documents. Geneva: World Health Organization.

8.

[Report] European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

9.

[Report] European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

10.

[Report] Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 25I-NBOMe. (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & Europol.

11.

[Report] Laboratory and Scientific Section, United Nations Office on Drugs and Crime. (2013) The challenge of new psychoactive substances. A report from the Global SMART Programme. Vienna: United Nations Office on Drugs and Crime.

12.

[Article] Galvin, Brian (2013) Annual review of the drug situation in Europe. Drugnet Ireland, Issue 46, Summer 2013. pp. 5-6.

13.

[Report] European Monitoring Centre for Drugs and Drug Addiction. (2004) Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

14.

[Report] European Monitoring Centre for Drugs and Drug Addiction. (1999) Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.